Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Alex Martin
AddedMar 31, 2024
UpdatedMay 31, 2026
Alex Martin

Alex Martin

Board Member, RenalGuard Solutions

LinkedIn

Alex Martin's Career

RenalGuard Solutions
RenalGuard Solutions

Milford, MA, US

Board Member· Board
NeoChord
NeoChord

St. Louis Park, MN, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Alex Martin's Career

RenalGuard Solutions
RenalGuard Solutions
Public$21.5M321982Milford, MA, US
Board Member· Board

Leadership at RenalGuard Solutions

Ilya BudikIlya BudikCEO
Ethan BenovitzEthan BenovitzBoard Member

Similar to RenalGuard Solutions

Specialty Renal ProductsSpecialty Renal ProductsSouth Orange, NJ, USMedical Devicesest. 2018Specialty Renal ProductsSouth Orange, NJ, US · est. 2018

Specialty Renal Products, Inc.: Developing innovative medical devices for renal disease patients.

Series A · $3M30
RenalertRenalertBaltimore, MD, USKidney Monitoringest. 2016RenalertBaltimore, MD, US · est. 2016

Renalert: Real-time kidney monitoring for early detection of acute injury, analyzing urine output, blood pressure, and oxygenation.

Angel · $175k1
NephrosantNephrosantSan Mateo, CA, USMedical Devicesest. 2017NephrosantSan Mateo, CA, US · est. 2017

NephroSant: Pioneering kidney health monitoring and early detection tools.

Series A · $16M27
Guard MedicalGuard MedicalMiami, FL, USMedical Devicesest. 2020Guard MedicalMiami, FL, US · est. 2020

Guard Medical: Innovating devices to reduce surgical infections and enhance healing.

Series B · $16M8
NeoChord
NeoChord
Seed$89.9M242009St. Louis Park, MN, US
Board Member· Board

Leadership at NeoChord

Nicole J WalkerNicole J WalkerBoard Member
David ChungDavid ChungCEO
Mudit K JainMudit K JainBoard Member
Casey TanseyCasey TanseyBoard Member
John SeabergJohn SeabergFounder
Andrew ElbardissiAndrew ElbardissiBoard Member

Similar to NeoChord

Cardiac DimensionsCardiac DimensionsKirkland, WA, USMedical Devicesest. 2001Cardiac DimensionsKirkland, WA, US · est. 2001

US-based Cardiac Dimensions develops global medical devices for heart failure and mitral valve treatment.

Public · $209.7M62
Nectero MedicalNectero MedicalDover, DE, USMedical Devicesest. 2017Nectero MedicalDover, DE, US · est. 2017

Nectero Medical: Innovating treatments to stabilize and prevent abdominal aortic aneurysms.

Series C · $19.5M14
NeocisNeocisMiami, FL, USSurgical Robotsest. 2009NeocisMiami, FL, US · est. 2009

Neocis: Revolutionizing dental surgery with advanced, robot-assisted implant technology.

Series D · $183.1M175
NicoNicoIndianapolis, IN, USMedical Devicesest. 2007NicoIndianapolis, IN, US · est. 2007

NICO Corp: Global provider of innovative medical devices for minimally invasive neuro and spinal surgeries.

Series B · $68.1M104

Alex Martin's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Alex Martin

James SyngeJames SyngeBoard Member · Life360Magnus ChristersonMagnus ChristersonBoard Member · Neo4jJim ScopaJim ScopaBoard Member · OneVenturesAlex GoldsteinAlex GoldsteinBoard Member · VaporoxRon GerlitzRon GerlitzCEO · Chord